These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21659770)

  • 21. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).
    Luo Y; Zhang W; Qin G
    Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 38963028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential urine biomarkers for the diagnosis of prediabetes and early diabetic nephropathy based on ISN CKHDP program.
    Gu D; Chen Y; Masucci M; Xiong C; Zou H; Holthofer H
    Clin Nephrol; 2020; 93(1):129-133. PubMed ID: 32145759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.
    Zubiri I; Posada-Ayala M; Benito-Martin A; Maroto AS; Martin-Lorenzo M; Cannata-Ortiz P; de la Cuesta F; Gonzalez-Calero L; Barderas MG; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
    Transl Res; 2015 Nov; 166(5):474-484.e4. PubMed ID: 26072307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
    Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary exosomes and diabetic nephropathy: a proteomic approach.
    Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
    Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic discovery of diabetic nephropathy biomarkers.
    Merchant ML; Klein JB
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):480-6. PubMed ID: 21044770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?
    Papale M; Di Paolo S; Vocino G; Rocchetti MT; Gesualdo L
    J Nephrol; 2014 Jun; 27(3):221-8. PubMed ID: 24567069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Liu H; Hou X; Cheng J
    Nephrology (Carlton); 2009 Apr; 14(3):332-7. PubMed ID: 19143942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of early circulating biomolecules associated with diabetes nephropathy - Ideal candidates for early biomarker array test for DN.
    Quan KY; Yap CG; Jahan NK; Pillai N
    Diabetes Res Clin Pract; 2021 Dec; 182():109122. PubMed ID: 34742785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy, a targeted treatment for diabetic nephropathy.
    Lin X; Tao L; Tang D
    Curr Med Chem; 2013; 20(30):3774-84. PubMed ID: 23895680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic nephropathy: An update on pathogenesis and drug development.
    A/L B Vasanth Rao VR; Tan SH; Candasamy M; Bhattamisra SK
    Diabetes Metab Syndr; 2019; 13(1):754-762. PubMed ID: 30641802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
    Currie GE; von Scholten BJ; Mary S; Flores Guerrero JL; Lindhardt M; Reinhard H; Jacobsen PK; Mullen W; Parving HH; Mischak H; Rossing P; Delles C
    Cardiovasc Diabetol; 2018 Apr; 17(1):50. PubMed ID: 29625564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system.
    Vitova L; Tuma Z; Moravec J; Kvapil M; Matejovic M; Mares J
    BMC Nephrol; 2017 Mar; 18(1):112. PubMed ID: 28359252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics in diabetic nephropathy.
    Kim HJ; Yoo HS; Kim CW
    Proteomics Clin Appl; 2008 Mar; 2(3):301-11. PubMed ID: 21136835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis.
    Papadopoulou-Marketou N; Chrousos GP; Kanaka-Gantenbein C
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27457509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
    Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
    Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic nephropathy in type 1 diabetes.
    Papadopoulou-Marketou N; Paschou SA; Marketos N; Adamidi S; Adamidis S; Kanaka-Gantenbein C
    Minerva Med; 2018 Jun; 109(3):218-228. PubMed ID: 29205998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary afamin levels are associated with the progression of diabetic nephropathy.
    Kaburagi Y; Takahashi E; Kajio H; Yamashita S; Yamamoto-Honda R; Shiga T; Okumura A; Goto A; Fukazawa Y; Seki N; Tobe K; Matsumoto M; Noda M; Unoki-Kubota H
    Diabetes Res Clin Pract; 2019 Jan; 147():37-46. PubMed ID: 29522788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of diabetic nephropathy-selective proteins in human plasma by multi-lectin affinity chromatography and LC-MS/MS.
    Ahn JM; Kim BG; Yu MH; Lee IK; Cho JY
    Proteomics Clin Appl; 2010 Jul; 4(6-7):644-53. PubMed ID: 21137083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.